Table 3.

Progress towards 2001 WHO research priorities: HSV-2 mathematical modelling

2001 WHO research priority: mathematical modelling	Has the priority been addressed?			Explanation
	Yes	Partially	No
Further models of HSV-2 transmission, control measures and interaction with HIV				Multiple studies carried out for HSV-2 transmission (3), control measures (5) and interaction with HIV (9)
Modelling risk of antiviral resistance				0 studies on modelling the risk of antiviral resistance; however, there were non-modelling studies on aciclovir resistance
Modelling the cost-effectiveness of specific control measures				Two studies carried out on cost-effectiveness of control measures, further analysis recommended
Modelling the potential effect of a HSV-2 vaccine				Two studies carried out to model the effect of a vaccine, many more studies emphasised its importance

HSV-2, herpes simplex virus type 2.